As shown in Figure 2A, the TNFAIP2 mRNA expression levels are upregulated in PAAD (Pancreatic Adenocarcinoma), OV (Ovarian Serous Cystadenocarcinoma), CHOL (Cholangio Carcinoma), CESC (Cervical Squamous Cell Carcinoma and Endocervical adenocarcinoma), KIRP (Kidney Renal Papillary Cell Carcinoma), THYM (Thymoma), UCEC (Uterine Corpus Endometrial Carcinoma), etc. In contrast, it is downregulated in KICH (Kidney Chromophobe), ACC (Adrenocortical Carcinoma), PCPG (Pheochromocytoma and Paraganglioma), PRAD (Prostate Adenocarcinoma), LUAD (Lung Adenocarcinoma), etc. The gene discussed is TNFAIP2; the disease is pancreatic adenocarcinoma.